Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge (Q43818454)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 June 2007

Language	Label	Description	Also known as
English	Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge	scientific article published on 21 June 2007

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

0 references

5

object named as

Nils Y Lycke

1 reference

Europe PubMed Central

27 November 2017

author name string

Monica M McNeal

1

1 reference

Europe PubMed Central

27 November 2017

Mitali Basu

2

1 reference

Europe PubMed Central

27 November 2017

Judy A Bean

3

1 reference

Europe PubMed Central

27 November 2017

John D Clements

4

1 reference

Europe PubMed Central

27 November 2017

Anna Ramne

6

1 reference

Europe PubMed Central

27 November 2017

Björn Löwenadler

7

1 reference

Europe PubMed Central

27 November 2017

Anthony H-C Choi

8

1 reference

Europe PubMed Central

27 November 2017

Richard L Ward

9

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

21 June 2007

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

25

1 reference

Europe PubMed Central

27 November 2017

33

1 reference

Europe PubMed Central

27 November 2017

6224-6231

1 reference

Europe PubMed Central

27 November 2017

Rotavirus and severe childhood diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Failure of live, attenuated oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.065

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.05.065

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43818454&oldid=2103622190"